COMMUNIQUÉS West-GlobeNewswire

Medtronic Announces First Economic Analysis Demonstrating Benefits of Professional CGM in People with Type 2 Diabetes

25/10/2017 - 15:00

DUBLIN - October 25, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced data from the first economic analysis conducted on the use of professional continuous glucose monitoring ( [...]

Summit Therapeutics plc : Grant of share options

25/10/2017 - 15:00

Summit Therapeutics plc ('Summit' or the 'Company') GRANT OF SHARE OPTIONS TO DIRECTORS, PDMRS AND EMPLOYEES AND GRANT OF RESTRICTED STOCK UNITS TO NON-EXECUTIVE DIRECTORS Oxford, UK, 25 October 2017 - Summit [...]

CapsoVision, Inc. Announces CE Mark for the Use of CapsoCam Plus Capsule Endoscopy System in Patients Ages 2 and Above

25/10/2017 - 14:00

Award-winning technology provides 360º imaging, eliminates need for receiver equipment during examination SARATOGA, Calif., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Today Silicon Valley-based CapsoVision, Inc. announced CE [...]

SUSPENSION OF TRADING IN ABLYNX SHARES ON EURONEXT BRUSSELS

25/10/2017 - 13:09

REGULATED INFORMATION GHENT, Belgium, 25 October 2017 (1 pm CEST) - Trading in the shares of Ablynx NV [Euronext Brussels: ABLX; OTC: ABYLY] was suspended at the request of the Company on 25 October 2017 as from 1 pm [...]

Shire Receives Orphan Drug Designation for Gene Therapy Candidate SHP654 (BAX 888) for the Treatment of Hemophilia A

25/10/2017 - 13:00

Shire Receives Orphan Drug Designation for Gene Therapy Candidate SHP654 (BAX 888) for the Treatment of Hemophilia A SHP654 investigational new drug (IND) application accepted by the FDA Lexington, MA - October 25, 2017 [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

25/10/2017 - 09:00

FIT Biotech Oy Company release October 25, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

Ambu acquires Invendo Medical and enters market of 70 million gastro procedures annually

25/10/2017 - 08:33

Ambu fast-forwards it's single-use endoscopy business. The purchase price of EUR 225 million includes contingent payments of up to EUR 110 million. Today, Ambu has acquired Invendo Medical GmbH. Invendo Medical is a [...]

CellaVision AB: Interim report January - September 2017

25/10/2017 - 08:20

An in-between quarter though with stronger market presence as well as product sales approval in the USA 1 juli-30 september 2017 1 januari-30 september 2017 Net sales decreased by 10 % to SEK 61.3 million (68.3) Organic [...]

Nexstim raises EUR 1.75 million via a directed issue of new shares to London-based investor City Financial - Funds to be used to support beginning the commercialisation of its NBT® system

25/10/2017 - 08:00

Company announcement, Helsinki, 25 October 2017 at 9:00 am Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a medical technology company developing and marketing pioneering navigated non-invasive brain [...]

uniQure Announces Pricing of its Public Offering

25/10/2017 - 02:14

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Oct. 24, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe unmet medical [...]

ABLYNX PRICES $200 MILLION INITIAL PUBLIC OFFERING IN THE UNITED STATES

25/10/2017 - 02:07

REGULATED INFORMATION - INSIDE INFORMATION 25 October 2017 - 2 am CEST GHENT, Belgium, 25 October 2017 - Ablynx NV [Euronext Brussels: ABLX; OTC: ABYLY] , a late-stage clinical biopharmaceutical company utilising its [...]

Stryker to acquire VEXIM

24/10/2017 - 22:00

Kalamazoo, Michigan - October 24, 2017 - Stryker Corporation (NYSE:SYK) announced that it has acquired control of VEXIM, a French medical device company listed on the Euronext Growth stock exchange in France. VEXIM, [...]

Sanofi Files Suit in the U.S. to Defend Its Patent Rights on Lantus® and Lantus® SoloStar®

24/10/2017 - 22:04

Sanofi Files Suit in the U.S. to Defend Its Patent Rights on Lantus ® and Lantus ® SoloStar ® Paris, France - October 24, 2017 - Sanofi (EURONEXT: SAN and NYSE: SNY) today filed a patent infringement suit against Mylan [...]

Sanofi intente une action en justice aux États-Unis pour défendre les brevets de Lantus® et de Lantus® SoloStar®

24/10/2017 - 22:04

Sanofi intente une action en justice aux États-Unis pour défendre les brevets de Lantus ® et de Lantus ® SoloStar ® Paris, France - Le 24 octobre 2017 - Sanofi (EURONEXT: SAN et NYSE: SNY) annonce aujourd'hui avoir [...]

Ossur Hf : Q3 Results 2017

24/10/2017 - 22:00

Highlights Sales in the third quarter of 2017 amounted to USD 139 million, corresponding to 5% growth and 3% organic growth, both measured in local currency. Growth in the quarter was negatively impacted by fewer [...]

Telix Pharmaceuticals Limited lance une introduction en bourse de 50 millions de dollars (ASX : TLX)

24/10/2017 - 21:12

MELBOURNE, Australie, le 24 octobre 2017 (GLOBE NEWSWIRE) - Telix Pharmaceuticals Limited ( Telix , la Société ), une société biopharmaceutique australienne axée sur le développement de produits de diagnostic et [...]

Telix Pharmaceuticals et ANMI s'associent en partenariat pour l'imagerie du cancer de la prostate

24/10/2017 - 18:11

MELBOURNE, Australie et LIÈGE, Belgique, 2017-10-24 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited ( Telix, la Société ), une société biopharmaceutique au stade clinique axée sur le développement de produits de [...]

DDF notes major collaboration between portfolio company Alector and AbbVie to advance novel class of immune therapies for patients with Alzheimer's disease

24/10/2017 - 15:27

DDF notes major collaboration between portfolio company Alector and AbbVie to advance novel class of immune therapies for patients with Alzheimer's disease DDF invested in San Francisco company Alector in Q4 2015 [...]

U.S. FDA grants orphan drug designation to glepaglutide for the treatment of short bowel syndrome

24/10/2017 - 12:43

Company announcement - No. 48/2017 U.S. FDA grants orphan drug designation to glepaglutide for the treatment of short bowel syndrome Copenhagen, Denmark, October 24, 2017 - The U.S. Food and Drug Administration (FDA) [...]